Treatment Effects of Narrative Exposure Therapy
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00660439|
Recruitment Status : Unknown
Verified April 2008 by University of Bergen.
Recruitment status was: Recruiting
First Posted : April 17, 2008
Last Update Posted : April 17, 2008
|Condition or disease||Intervention/treatment||Phase|
|Posttraumatic Stress Disorder||Behavioral: Narrative Exposure Therapy||Phase 2|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||40 participants|
|Intervention Model:||Crossover Assignment|
|Masking:||None (Open Label)|
|Official Title:||Treatment Effects of Narrative Exposure Therapy on Psychiatric Symptoms and Cortisol Levels in Patients With Posttraumatic Stress Disorder|
|Study Start Date :||May 2007|
|Estimated Primary Completion Date :||December 2009|
|Estimated Study Completion Date :||November 2010|
Treatment group, receives Narrative Exposure Therapy immediately after first assessment. Patients are assessed 1 and 6 months after treatment.
Behavioral: Narrative Exposure Therapy
Psychological treatment, with narration of positive and traumatic events in patients history, including "in vivo" exposure of traumatic events. The narrative is written down by the therapist.
Other Name: NET
No Intervention: B
Waiting list control group, receives no intervention for 3 months after first assessment. A second assessment is then administered and patients receives Narrative Exposure Therapy. Patients are assessed 1 and 6 months after treatment.
- Psychiatric symptoms [ Time Frame: 1 and 6 months after treatment ]
- Cortisol in saliva [ Time Frame: 1 and 6 months after treatment ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00660439
|Contact: Tove S. Nordling, Cand Psychol||+47 email@example.com|
|Western Norway Violence and Traumatic Stress Resource Centre||Recruiting|
|Bergen, Norway, 5021|
|Contact: Tove S. Nordling, Cand Psychol +47 55 97 66 91 firstname.lastname@example.org|
|Sub-Investigator: Tove S. Nordling, Cand Psychol|
|Study Director:||Anne Marita Milde, PhD||University of Bergen|